Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
130.66
+2.20 (1.71%)
At close: Aug 19, 2026, 4:00 PM EDT
130.05
-0.61 (-0.47%)
Pre-market: Aug 20, 2026, 8:52 AM EDT
Insmed Stock Forecast
Stock Price Forecast
According to 23 analysts polled by S&P Global, Insmed stock has a consensus rating of "Strong Buy" and an average price target of $200.05. The average 1-year stock price forecast is 53.11% higher than the current stock price, while the lowest is $169 (+29.34%) and the highest is $243 (+85.98%).
Price Target: $200.05 (+53.11%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Insmed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 17 | 17 | 17 | 18 | 18 |
| Buy | 3 | 4 | 5 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 21 | 22 | 22 | 23 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $218 | Buy | Maintains | $218 | +66.85% | Aug 14, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $185 → $195 | Buy | Reiterates | $185 → $195 | +49.24% | Aug 10, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $179 → $175 | Buy | Reiterates | $179 → $175 | +33.94% | Aug 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $220 | Buy | Maintains | $220 | +68.38% | Aug 10, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $235 | Buy | Maintains | $235 | +79.86% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
1.81B
from 606.42M
Increased by 197.88%
Revenue Next Year
2.87B
from 1.81B
Increased by 58.73%
EPS This Year
-1.55
from -6.42
EPS Next Year
0.72
from -1.55
EPS and Forward PE are based on non-GAAP adjusted numbers.